So, I'm heavily invested in NYR, have been for many years, but I still think this has a long way to fall.
- The company has been close to a decade in preclinical and are yet to show any expertise in running clinical trials.
- Their previous (lead) drug, treating high cholesterol failed due to toxic side effects
- Still haven't secured patent IP protection for their asset
- NYR has a long track record of missed and slipped timelines
- NOX owns a large chunk of NYR, and NOX will start offloading at any positive price movements. This is a massive anchor around NYR neck.
- They don't seem to have a plan B if the current TBI drug fails in Phase 1 (as 90%+ of drugs do).
- The much-hoped for Walter Reed funding will be non-existent under a Trump presidency.
- Forums
- ASX - By Stock
- NYR
- Ann: Nyrada Commences Walter Reed Traumatic Brain Injury Study
NYR
nyrada inc.
Add to My Watchlist
0.00%
!
29.0¢

Ann: Nyrada Commences Walter Reed Traumatic Brain Injury Study, page-176
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
29.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $61.32M |
Open | High | Low | Value | Volume |
29.0¢ | 29.0¢ | 28.0¢ | $159.0K | 561.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 25000 | 29.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.5¢ | 34962 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 8947 | 0.290 |
4 | 74000 | 0.285 |
3 | 78029 | 0.280 |
4 | 79706 | 0.275 |
2 | 17400 | 0.270 |
Price($) | Vol. | No. |
---|---|---|
0.295 | 34962 | 2 |
0.300 | 66300 | 3 |
0.305 | 45000 | 2 |
0.310 | 31700 | 2 |
0.320 | 138150 | 2 |
Last trade - 11.17am 07/08/2025 (20 minute delay) ? |
Featured News
NYR (ASX) Chart |